Calla Lily Clinical Care begins dosing in trial of intravaginal platform for threatened miscarriage PharmaTimes 11:35 Thu, 07 May
Calla Lily Clinical Care Doses First Patients in Clinical Trial for Intravaginal Drug Delivery Platform for Threatened Miscarriage Business Wire (Press Release) 09:47 Wed, 06 May